|
1
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parfitt AM: Targeted and nontargeted bone
remodeling: relationship to basic multicellular unit origination
and progression. Bone. 30:5–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: a novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kong YY, Yoshida H, Sarosi I, Tan HL,
Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G,
Itie A, et al: OPGL is a key regulator of osteoclastogenesis,
lymphocyte development and lymph-node organogenesis. Nature.
397:315–323. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mizuno A, Amizuka N, Irie K, Murakami A,
Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, et
al: Severe osteoporosis in mice lacking osteoclastogenesis
inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun.
247:610–615. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hikiji H, Takato T, Shimizu T and Ishii S:
The roles of prostanoids, leukotrienes, and platelet-activating
factor in bone metabolism and disease. Prog Lipid Res. 47:107–126.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blackwell KA, Raisz LG and Pilbeam CC:
Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab.
21:294–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Agas D, Marchetti L, Hurley MM and
Sabbieti MG: Prostaglandin F2α: a bone remodeling
mediator. J Cell Physiol. 228:25–29. 2013. View Article : Google Scholar
|
|
10
|
Kuroyanagi G, Tokuda H,
Matsushima-Nishiwaki R, Kondo A, Mizutani J, Kozawa O and Otsuka T:
Resveratrol suppresses prostaglandin F2α-induced
osteoprotegerin synthesis in osteoblasts: inhibition of the MAP
kinase signaling. Arch Biochem Biophys. 542:39–45. 2014. View Article : Google Scholar
|
|
11
|
Hirano T: Revisiting the 1986 molecular
cloning of interleukin 6. Front Immunol. 5:4562014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Franchimont N, Wertz S and Malaise M:
Interleukin-6: an osteotropic factor influencing bone formation?
Bone. 37:601–606. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tokuda H, Kozawa O, Harada A and Uematsu
T: p42/p44 mitogen-activated protein kinase activation is involved
in prostaglandin F2α-induced interleukin-6 synthesis in
osteoblasts. Cell Signal. 11:325–330. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minamitani C, Otsuka T, Takai S,
Matsushima-Nishiwaki R, Adachi S, Hanai Y, Mizutani J, Tokuda H and
Kozawa O: Involvement of Rho-kinase in prostaglandin
F2α-stimulated interleukin-6 synthesis via p38
mitogen-activated protein kinase in osteoblasts. Mol Cell
Endocrinol. 291:27–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Warnecke C, Griethe W, Weidemann A,
Jürgensen JS, Willam C, Bachmann S, Ivashchenko Y, Wagner I, Frei
U, Wiesener M and Eckardt KU: Activation of the hypoxia-inducible
factor-pathway and stimulation of angiogenesis by application of
prolyl hydroxylase inhibitors. FASEB J. 17:1186–1188.
2003.PubMed/NCBI
|
|
16
|
Schofield CJ and Ratcliffe PJ: Oxygen
sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 5:343–354.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knowles HJ, Cleton-Jansen AM, Korsching E
and Athanasou NA: Hypoxia-inducible factor regulates
osteoclast-mediated bone resorption: role of angiopoietin-like 4.
FASEB J. 24:4648–4659. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Wan C, Deng L, Liu X, Cao X,
Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC,
et al: The hypoxia-inducible factor alpha pathway couples
angiogenesis to osteogenesis during skeletal development. J Clin
Invest. 117:1616–1626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wan C, Gilbert SR, Wang Y, Cao X, Shen X,
Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC,
et al: Activation of the hypoxia-inducible factor-1α pathway
accelerates bone regeneration. Proc Natl Acad Sci USA. 105:686–691.
2008. View Article : Google Scholar
|
|
20
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2
in osteoblast-like cells. Exp Cell Res. 198:130–134. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simpson DA, Feeney S, Boyle C and Stitt
AW: Retinal VEGF mRNA measured by SYBR green I fluorescence: a
versatile approach to quantitative PCR. Mol Vis. 6:178–183.
2000.PubMed/NCBI
|
|
23
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells.
J Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen X, Wan C, Ramaswamy G, Mavalli M,
Wang Y, Duvall CL, Deng LF, Guldberg RE, Eberhart A, Clemens TL and
Gilbert SR: Prolyl hydroxylase inhibitors increase neoangiogenesis
and callus formation following femur fracture in mice. J Orthop
Res. 27:1298–1305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Donneys A, Deshpande SS, Tchanque-Fossuo
CN, Johnson KL, Blough JT, Perosky JE, Kozloff KM, Felice PA,
Nelson NS, Farberg AS, et al: Deferoxamine expedites consolidation
during mandibular distraction osteogenesis. Bone. 55:384–390. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan L, Li J, Yu Z, Dang X and Wang K: The
hypoxia-inducible factor pathway, prolyl hydroxylase domain protein
inhibitors, and their roles in bone repair and regeneration. BioMed
Res Int. 2014:2393562014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001.PubMed/NCBI
|
|
29
|
Widmann C, Gibson S, Jarpe MB and Johnson
GL: Mitogen-activated protein kinase: conservation of a
three-kinase module from yeast to human. Physiol Rev. 79:143–180.
1999.PubMed/NCBI
|
|
30
|
Erlebacher A, Filvaroff EH, Gitelman SE
and Derynck R: Toward a molecular understanding of skeletal
development. Cell. 80:371–378. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zelzer E and Olsen BR: Multiple roles of
vascular endothelial growth factor (VEGF) in skeletal development,
growth, and repair. Curr Top Dev Biol. 65:169–187. 2005. View Article : Google Scholar : PubMed/NCBI
|
